Risk factors for potential drug-drug interactions in intensive care unit patients

被引:37
|
作者
Jankovic, Slobodan M. [1 ]
Pejcic, Ana V. [1 ]
Milosavljevic, Milos N. [1 ]
Opancina, Valentina D. [1 ]
Pesic, Nikola V. [1 ]
Nedeljkovic, Tamara T. [1 ]
Babic, Goran M. [2 ]
机构
[1] Univ Kragujevac, Fac Med Sci, Pharmacol & Toxicol Dept, Svetozara Markovica 69, Kragujevac 34000, Serbia
[2] Univ Kragujevac, Fac Med Sci, Dept Gynecol & Obstet, Svetozara Markovica 69, Kragujevac 34000, Serbia
关键词
Drug-drug interactions; Intensive care unit; Risk factors; POLYPHARMACY; PREVALENCE; MEDICATIONS; PREDICTORS; FREQUENCY; IMPACT;
D O I
10.1016/j.jcrc.2017.08.021
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: To determine risk factors for each severity-based category of potential drug-drug interactions (DDIs) encountered at intensive care unit (ICU) patients. Methods: This was a retrospective cohort analysis of patients treated at the ICU of the Clinical Center Kragujevac, a public tertiary care hospital in Kragujevac, Serbia. Three interaction checkers were used to reveal drug-drug interactions: Medscape, Epocrates and Micromedex. Results: The study included 201 patients, 66.19 +/- 16.11 years of age. Average number of DDIs per patient ranged from 10.49 +/- 8.80 (Micromedex) to 29.43 +/- 21.51 (Medscape). Antiarrhythmic or anticonvulsant drug prescription, Charlson Comorbidity Index, male sex, length of hospitalization, number of drugs or therapeutic groups prescribed and surgery increased the risk of DDIs in ICU patients, while presence of delirium or dementia and transfer from emergency department to ICU protected against. Conclusions: The rate of the DDIs in ICU patients at a tertiary care hospital is high, and adversely influenced by number of drugs or drug groups prescribed per patient, antiarrhythmic or anticonvulsant drug prescription, comorbidities, length of hospitalization and surgery. On the other hand, presence of cognitive deficit and transfer from emergency department to ICU protect ICU patients from the DDIs. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [41] Prevalence of potential drug-drug interactions in breast cancer patients and determination of their risk factors
    Bibi, Rashida
    Azhar, Saira
    Iqbal, Ayesha
    Jabeen, Hajera
    Kalsoom, Umm-e
    Iqbal, Muhammad M.
    Nazeer, Maria
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1616 - 1622
  • [42] Risk factors for contraindicated potential drug-drug interactions in acute intracerebral hemorrhage patients
    Aleksic, D.
    Toncev, G.
    Drakulic, S. Miletic
    Milosavljevic, M.
    Jankovic, S.
    Stefanovic, S.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 363 - 363
  • [43] Risk factors for potential drug-drug interactions in patients with chronic obstructive pulmonary disease
    Dobrivoje Stojadinovic
    Radica Zivkovic Zaric
    Slobodan Jankovic
    Zorica Lazic
    Ivan Cekerevac
    Romana Susa
    [J]. Irish Journal of Medical Science (1971 -), 2020, 189 : 1123 - 1125
  • [44] Risk factors for potential drug-drug interactions in patients with chronic obstructive pulmonary disease
    Stojadinovic, Dobrivoje
    Zaric, Radica Zivkovic
    Jankovic, Slobodan
    Lazic, Zorica
    Cekerevac, Ivan
    Susa, Romana
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (03) : 1123 - 1125
  • [45] Risk factors for potential drug-drug interactions of statins in patients with acute coronary syndrome
    Pejcic, Ana, V
    Jankovic, Slobodan M.
    Davidovic, Goran
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58
  • [46] Evaluation of Potential Drug-Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis
    Fitzmaurice, Mary Grace
    Wong, Adrian
    Akerberg, Hannah
    Avramovska, Simona
    Smithburger, Pamela L.
    Buckley, Mitchell S.
    Kane-Gill, Sandra L.
    [J]. DRUG SAFETY, 2019, 42 (09) : 1035 - 1044
  • [47] Variable Linezolid Exposure in Intensive Care Unit PatientsPossible Role of Drug-Drug Interactions
    Toepper, Christoph
    Steinbach, Catherine L.
    Dorn, Christoph
    Kratzer, Alexander
    Wicha, Sebastian G.
    Schleibinger, Michael
    Liebchen, Uwe
    Kees, Frieder
    Salzberger, Bernd
    Kees, Martin G.
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (05) : 573 - 578
  • [48] Risk factors for potential drug-drug interactions in a general neurology ward
    Kostic, Marina J.
    Zaric, Radica S. Zivkovic
    Jankovic, Slobodan M.
    [J]. VOJNOSANITETSKI PREGLED, 2021, 78 (06) : 607 - 614
  • [49] Potential drug-drug interactions when managing status epilepticus patients in intensive care: A cohort study
    Le Roux, Clementine
    Destere, Alexandre
    Hervy, Sarah
    Lloret-Linares, Celia
    Reignier, Jean
    Caillet, Pascal
    Jolliet, Pascale
    Megarbane, Bruno
    Boels, David
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2408 - 2418
  • [50] Assessment of the risk of QT-interval prolongation associated with potential drug-drug interactions in patients admitted to Intensive Care Units
    Fernandes, Flavia Medeiros
    da Silva Paulino, Aryelle Mayara
    Sedda, Bruna Camelo
    da Silva, Eliane Pereira
    Martins, Rand Randall
    Oliveira, Antonio Gouveia
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2019, 27 (02) : 229 - 234